Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Beating Heart Mitral Valve Repair With the HARPOON™ System

NCT: NCT04375332 · ACTIVE_NOT_RECRUITING

NCT IDNCT04375332
StatusACTIVE_NOT_RECRUITING
Start Date2020-12-16
Completion2027-12-20
SponsorEdwards Lifesciences (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of the study is to evaluate the safety and effectiveness of the HARPOON™ System in the treatment of patients with severe degenerative mitral regurgitation (DMR).

Frequently Asked Questions

What is Beating Heart Mitral Valve Repair With the HARPOON™ System?

Beating Heart Mitral Valve Repair With the HARPOON™ System is a clinical trial registered under NCT04375332. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04375332?

The current status of NCT04375332 (Beating Heart Mitral Valve Repair With the HARPOON™ System) is: ACTIVE_NOT_RECRUITING.

When did Beating Heart Mitral Valve Repair With the HARPOON™ System start?

Beating Heart Mitral Valve Repair With the HARPOON™ System started on 2020-12-16.

Related Devices

PMA P220003Mitral valve repair devicesEdwards Lifesciences, LLC PMA P250019Prosthesis, mitral valve, percutaneously deliveredEdwards Lifesciences, LLC PMA P150036heart-valve, non-allograft tissueEdwards Lifesciences, LLC PMA P150048heart-valve, non-allograft tissueEdwards Lifesciences, LLC PMA P860057replacement Heart-valveEdwards Lifesciences, LLC

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑